{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:43:35Z","timestamp":1789753415009,"version":"4.0.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bodossaki Postdoctoral Research Fellowship"},{"name":"EMBO Scientific Exchange Grant","award":["STF_11143"],"award-info":[{"award-number":["STF_11143"]}]},{"DOI":"10.13039\/501100001866","name":"Fonds National de la Recherche Luxembourg","doi-asserted-by":"publisher","award":["PRIDE21\/16749720"],"award-info":[{"award-number":["PRIDE21\/16749720"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Luxemburg National Research Fund","award":["FNR9631103"],"award-info":[{"award-number":["FNR9631103"]}]},{"name":"European Union \u2013 NextGenerationEU","award":["TAEDR-0535850"],"award-info":[{"award-number":["TAEDR-0535850"]}]},{"name":"European Union HORIZON","award":["No 101099145"],"award-info":[{"award-number":["No 101099145"]}]},{"name":"Institute of Pharmaceutical Research and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hyperglycemia, a hallmark of diabetes mellitus, is a metabolic condition that highly affects the nervous system. While evidence from epidemiological and animal studies links diabetes to dopaminergic dysfunction and an increased risk of Parkinson\u2019s disease, the underlying mechanisms remain unclear. Here, we examined the effects of high glucose on human iPSC-derived dopaminergic neurons and glial cells to better understand the pathogenic alterations that lead to neurotoxicity. Previous implication of neurotrophins in the neurological manifestations of diabetes prompted us to focus on the role of p75NTR neurotrophin receptor (p75NTR) in dopaminergic neurodegeneration under hyperglycemic conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>iPSC-derived dopaminergic neurons, astrocytes and microglia were treated with high glucose (50mM, 100mM) for 48\u00a0h to simulate hyperglycemia. Cytotoxicity assays, RNA sequencing and DNA damage assessments were employed to investigate the pathological alterations induced by high glucose exposure in neurons. Pharmacological targeting of p75NTR activity allowed investigation of its involvement in glucose neurotoxicity. Glial-mediated neurotoxicity was evaluated using conditioned media and inflammatory marker analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>High glucose treatment led to DNA damage, activation of JNK signaling and cell death in neurons. Importantly, we observed upregulation of p75NTR and its pro-apoptotic ligand pro-NGF, suggesting activation of the pro-NGF\/p75NTR axis in high glucose-treated neurons. Inhibition of p75NTR activity rescued neuronal cell death, identifying p75NTR as a central mediator of glucose neurotoxicity. Furthermore, glucose overload sensitized neurons to 6-hydroxydopamine (6-OHDA), increasing their vulnerability to neurotoxic insults\u2014an effect reversed by p75NTR blockade. Treatment with BNN27, a synthetic NGF mimetic, prevented neuronal loss through p75NTR and TrkA receptors, suggesting neurotrophin signaling as a potential therapeutic target for combating high glucose-induced neuronal damage. Finally, we demonstrated the contribution of glial cells to neurodegeneration since high glucose treatment of iPSC-derived astrocytes and microglia enhanced their inflammatory potential and triggered the release of neurotoxic factors, causing pro-apoptotic effects on neurons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings show that high glucose impairs human dopaminergic neuron survival through activation of the pro-NGF\/p75NTR axis and indirect glia-mediated mechanisms. Targeting p75NTR signaling may offer neuroprotective benefits in diabetes-related neurodegeneration, particularly for patients at risk of Parkinson\u2019s disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-026-04965-y","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:36:06Z","timestamp":1774074966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting p75NTR activity alleviates the neurotoxic effect of high glucose on iPSC-derived dopaminergic neurons"],"prefix":"10.1186","volume":"17","author":[{"given":"Konstantina","family":"Chanoumidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Zota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Anna","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrystalla","family":"Konstantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Tsimpolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Electra","family":"Tsagliotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tziortziou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Ntarntani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Gr\u00fcnewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu David","family":"Lavigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Gravanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Charalampopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"key":"4965_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25021122","author":"A Abdyeva","year":"2024","unstructured":"Abdyeva A, Kurtova E, Savinkova I, Galkov M, Gorbacheva L. Long-term exposure of cultured astrocytes to high glucose impact on their LPS-induced activation. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25021122.","journal-title":"Int J Mol Sci"},{"key":"4965_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.prdoa.2024.100265","volume-title":"Clinical parkinsonism and related disorders","author":"Y Aguirre-Vidal","year":"2024","unstructured":"Aguirre-Vidal Y, Montes S, Mota-L\u00f3pez AC, Navarrete-V\u00e1zquez G. Antidiabetic drugs in Parkinson\u2019s disease. Clinical parkinsonism and related disorders. Elsevier Ltd. 2024;11. https:\/\/doi.org\/10.1016\/j.prdoa.2024.100265."},{"issue":"1","key":"4965_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3109\/02699052.2015.1088963","volume":"30","author":"J Alder","year":"2016","unstructured":"Alder J, Fujioka W, Giarratana A, Wissocki J, Thakkar K, Vuong P, Patel B, Chakraborty T, Elsabeh R, Parikh A, Girn HS, Crockett D, Thakker-Varia S. Genetic and pharmacological intervention of the p75NTR pathway alters morphological and behavioural recovery following traumatic brain injury in mice. Brain Injury. 2016;30(1):48\u201365. https:\/\/doi.org\/10.3109\/02699052.2015.1088963.","journal-title":"Brain Injury"},{"key":"4965_CR4","doi-asserted-by":"publisher","DOI":"10.2174\/1567205014666170117104053","author":"M Bahniwal","year":"2017","unstructured":"Bahniwal M, Little JP, Klegeris A. High glucose enhances neurotoxicity and inflammatory cytokine secretion by stimulated human astrocytes. Curr Alzheimer Res. 2017. https:\/\/doi.org\/10.2174\/1567205014666170117104053.","journal-title":"Curr Alzheimer Res"},{"key":"4965_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neulet.2015.10.054","volume":"610","author":"M Bains","year":"2016","unstructured":"Bains M, Roberts JL. Estrogen protects against dopamine neuron toxicity in primary mesencephalic cultures through an indirect P13K\/Akt mediated astrocyte pathway. Neurosci Lett. 2016;610:79\u201385. https:\/\/doi.org\/10.1016\/j.neulet.2015.10.054.","journal-title":"Neurosci Lett"},{"issue":"34","key":"4965_CR6","doi-asserted-by":"publisher","first-page":"8826","DOI":"10.1523\/JNEUROSCI.4278-15.2016","volume":"36","author":"PF Barcelona","year":"2016","unstructured":"Barcelona PF, Sitaras N, Galan A, Esquiva G, Jmaeff S, Jian Y, Sarunic MV, Cuenca N, Sapieha P, Saragovi HU. p75NTR and its ligand ProNGF activate paracrine mechanisms etiological to the vascular, inflammatory, and neurodegenerative pathologies of diabetic retinopathy. J Neurosci. 2016;36(34):8826\u201341. https:\/\/doi.org\/10.1523\/JNEUROSCI.4278-15.2016.","journal-title":"J Neurosci"},{"key":"4965_CR7","unstructured":"http:\/\/www.elsevier.com\/locate\/pneurobio"},{"key":"4965_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bcp.2016.08.001","volume":"117","author":"JP Bennett","year":"2016","unstructured":"Bennett JP, O\u2019Brien LC, Brohawn DG. Pharmacological properties of microneurotrophin drugs developed for treatment of amyotrophic lateral sclerosis. Biochem Pharmacol. 2016;117:68\u201377. https:\/\/doi.org\/10.1016\/j.bcp.2016.08.001.","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"4965_CR9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018; 14(10): 591\u2013604. https:\/\/doi.org\/10.1038\/s41574-018-0048-7","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"4965_CR10","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1007\/s12035-018-1025-9","volume":"55","author":"A Biosa","year":"2018","unstructured":"Biosa A, Outeiro TF, Bubacco L, Bisaglia M. Diabetes Mellitus as a Risk Factor for Parkinson\u2019s Disease: a molecular point of view. Mol Neurobiol. 2018;55(11):8754\u201363. https:\/\/doi.org\/10.1007\/s12035-018-1025-9.","journal-title":"Mol Neurobiol"},{"key":"4965_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.neuropharm.2015.04.006","volume":"95","author":"M Bourque","year":"2015","unstructured":"Bourque M, Morissette M, Di Paolo T. Neuroprotection in Parkinsonian-treated mice via estrogen receptor \u03b1 activation requires G protein-coupled estrogen receptor 1. Neuropharmacology. 2015;95:343\u201352. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.04.006.","journal-title":"Neuropharmacology"},{"issue":"1","key":"4965_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41583-022-00641-1","volume":"24","author":"AN Brandebura","year":"2023","unstructured":"Brandebura AN, Paumier A, Onur TS, Allen NJ. Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders. Nat Rev Neurosci. 2023; 24(1): 23\u201339. https:\/\/doi.org\/10.1038\/s41583-022-00641-1","journal-title":"Nat Rev Neurosci"},{"issue":"21","key":"4965_CR13","doi-asserted-by":"publisher","first-page":"6569","DOI":"10.1021\/jm900468p","volume":"52","author":"T Calogeropoulou","year":"2009","unstructured":"Calogeropoulou T, Avlonitis N, Minas V, Alexi X, Pantzou A, Charalampopoulos I, Zervou M, Vergou V, Katsanou ES, Lazaridis I, Alexis MN, Gravanis A. Novel dehydroepiandrosterone derivatives with antiapoptotic, neuroprotective activity. J Med Chem. 2009;52(21):6569\u201387. https:\/\/doi.org\/10.1021\/jm900468p.","journal-title":"J Med Chem"},{"issue":"6","key":"4965_CR14","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.celrep.2012.11.009","volume":"2","author":"I Charalampopoulos","year":"2012","unstructured":"Charalampopoulos I, Vicario A, Pediaditakis I, Gravanis A, Simi A, Ib\u00e1\u00f1ez CF. Genetic Dissection of Neurotrophin Signaling through the p75 Neurotrophin Receptor. Cell Rep. 2012;2(6):1563\u201370. https:\/\/doi.org\/10.1016\/j.celrep.2012.11.009.","journal-title":"Cell Rep"},{"key":"4965_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03818-w","author":"D Charou","year":"2024","unstructured":"Charou D, Rogdakis T, Latorrata A, Valcarcel M, Papadogiannis V, Athanasiou C, Tsengenes A, Papadopoulou MA, Lypitkas D, Lavigne MD, Katsila T, Wade RC, Cader MZ, Calogeropoulou T, Gravanis A, Charalampopoulos I. Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer\u2019s disease. Stem Cell Res Ther. 2024. https:\/\/doi.org\/10.1186\/s13287-024-03818-w.","journal-title":"Stem Cell Res Ther"},{"key":"4965_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.2174\/187152708787122923","volume":"7","author":"LW Chen","year":"2008","unstructured":"Chen LW, Yung KKL, Chan YS, Shum DKY, Bolam JP. The proNGF-p75NTR-sortilin signalling complex as new target for the therapeutic treatment of Parkinson\u2019s disease. CNS & Neurol Disord Drug Targets. 2008; 7: 512\u201323.","journal-title":"CNS & Neurol Disord Drug Targets"},{"key":"4965_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-025-00467-8","author":"L Chen","year":"2025","unstructured":"Chen L, Wang C, Qin L, Zhang H. Parkinson\u2019s disease and glucose metabolism impairment. Transl Neurodegen. 2025. https:\/\/doi.org\/10.1186\/s40035-025-00467-8.","journal-title":"Transl Neurodegen"},{"key":"4965_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.neuroscience.2018.07.048","volume":"388","author":"Y Chen","year":"2018","unstructured":"Chen Y, Hou Y, Yang J, Du R, Chen C, Chen F, Wang H, Ge R, Chen J. P75 involved in the ubiquitination of \u03b1-synuclein in rotenone-based Parkinson\u2019s disease models. Neuroscience. 2018;388:367\u201373. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.07.048.","journal-title":"Neuroscience"},{"key":"4965_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12781","author":"Y Chen","year":"2020","unstructured":"Chen Y, Qin C, Huang J, Tang X, Liu C, Huang K, Xu J, Guo G, Tong A, Zhou L. The role of astrocytes in oxidative stress of central nervous system: a mixed blessing. Cell Prolif. 2020. https:\/\/doi.org\/10.1111\/cpr.12781.","journal-title":"Cell Prolif"},{"issue":"11","key":"4965_CR20","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1007\/s00125-004-1550-0","volume":"47","author":"L Chilton","year":"2004","unstructured":"Chilton L, Middlemas A, Gardiner N, Tomlinson DR. The p75 neurotrophin receptor appears in plasma in diabetic rats\u2014characterisation of a potential early test for neuropathy. Diabetologia. 2004;47(11):1924\u201330. https:\/\/doi.org\/10.1007\/s00125-004-1550-0.","journal-title":"Diabetologia"},{"issue":"6","key":"4965_CR21","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/mds.28551","volume":"36","author":"H Chohan","year":"2021","unstructured":"Chohan H, Senkevich K, Patel RK, Bestwick JP, Jacobs BM, Ciga B, Gan-Or S, Z., Noyce AJ. Type 2 diabetes as a determinant of Parkinson\u2019s disease risk and progression. Mov Disord. 2021;36(6):1420\u20139. https:\/\/doi.org\/10.1002\/mds.28551.","journal-title":"Mov Disord"},{"issue":"5","key":"4965_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1056\/nejmoa1215740","volume":"20","author":"PK Crane","year":"2013","unstructured":"Crane PK, Walker R, Hubbard RA, Li G, Nathan DM, Zheng H, Haneuse S, Craft S, Montine TJ, Kahn SE, McCormick W, McCurry SM, Bowen JD, Larson EB. Glucose levels and risk of dementia. Forschende Komplementarmedizin. 2013; 20(5): 386\u20137. https:\/\/doi.org\/10.1056\/nejmoa1215740","journal-title":"Forschende Komplementarmedizin"},{"issue":"9","key":"4965_CR23","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.parkreldis.2009.02.013","volume":"15","author":"M D\u2019Amelio","year":"2009","unstructured":"D\u2019Amelio M, Ragonese P, Callari G, Di Benedetto N, Palmeri B, Terruso V, Salemi G, Famoso G, Aridon P, Savettieri G. Diabetes preceding Parkinson\u2019s disease onset. A case-control study. Parkinsonism Relat Disorders. 2009;15(9):660\u20134. https:\/\/doi.org\/10.1016\/j.parkreldis.2009.02.013.","journal-title":"Parkinsonism Relat Disorders"},{"key":"4965_CR24","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/S0140-6736(09)60553-5","volume":"373","author":"KM Dungan","year":"2009","unstructured":"Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373:1798\u2013807. https:\/\/doi.org\/10.1016\/S0140-6736(09)60553-5.","journal-title":"Lancet"},{"issue":"8","key":"4965_CR25","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1007\/s00125-019-4885-2","volume":"62","author":"SL Elshaer","year":"2019","unstructured":"Elshaer SL, Alwhaibi A, Mohamed R, Lemtalsi T, Coucha M, Longo FM, El-Remessy AB. Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway. Diabetologia. 2019a;62(8):1488\u2013500. https:\/\/doi.org\/10.1007\/s00125-019-4885-2.","journal-title":"Diabetologia"},{"issue":"8","key":"4965_CR26","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1007\/s00125-019-4885-2","volume":"62","author":"SL Elshaer","year":"2019","unstructured":"Elshaer SL, Alwhaibi A, Mohamed R, Lemtalsi T, Coucha M, Longo FM, El-Remessy AB. Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway. Diabetologia. 2019b;62(8):1488\u2013500. https:\/\/doi.org\/10.1007\/s00125-019-4885-2.","journal-title":"Diabetologia"},{"key":"4965_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2022.159266","author":"NM Fenton","year":"2023","unstructured":"Fenton NM, Nguyen TB, Sharpe LJ, Brown AJ. Refining sugar\u2019s involvement in cholesterol synthesis. Biochimica et Biophysica Acta Mol Cell Biol Lipids. 2023. https:\/\/doi.org\/10.1016\/j.bbalip.2022.159266.","journal-title":"Biochimica et Biophysica Acta Mol Cell Biol Lipids"},{"key":"4965_CR28","doi-asserted-by":"crossref","unstructured":"Friedman WJ. Neurotrophins induce death of hippocampal neurons via the p75 receptor; 2000.","DOI":"10.1523\/JNEUROSCI.20-17-06340.2000"},{"key":"4965_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01588-0","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther. 2023. https:\/\/doi.org\/10.1038\/s41392-023-01588-0.","journal-title":"Signal Transduct Target Ther"},{"key":"4965_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1758-5996-7-1","author":"RB Gelaleti","year":"2015","unstructured":"Gelaleti RB, Damasceno DC, Lima PHO, Salvadori DMF, Calderon IDMP, Pera\u00e7oli JC, Rudge MVC. Oxidative DNA damage in diabetic and mild gestational hyperglycemic pregnant women. Diabetol Metab Syndr. 2015. https:\/\/doi.org\/10.1186\/1758-5996-7-1.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"4965_CR31","first-page":"85","volume":"80","author":"S Gomperts","year":"2013","unstructured":"Gomperts S, Locascio JJ, Rentz D, Santarlasci A, Marquie M, Johnson KA, Growdon JH. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Am Acad Neurol. 2013;80(1):85\u201391.","journal-title":"Am Acad Neurol"},{"issue":"6","key":"4965_CR32","doi-asserted-by":"publisher","first-page":"9005","DOI":"10.18632\/oncotarget.14667","volume":"8","author":"A Gravanis","year":"2017","unstructured":"Gravanis A, Pediaditakis I, Charalampopoulos I. Synthetic microneurotrophins in therapeutics of neurodegeneration. Oncotarget. 2017;8(6):9005\u20136. https:\/\/doi.org\/10.18632\/oncotarget.14667.","journal-title":"Oncotarget"},{"issue":"6","key":"4965_CR33","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.stemcr.2017.05.017","volume":"8","author":"W Haenseler","year":"2017","unstructured":"Haenseler W, Sansom SN, Buchrieser J, Newey SE, Moore CS, Nicholls FJ, Chintawar S, Schnell C, Antel JP, Allen ND, Cader MZ, Wade-Martins R, James WS, Cowley SA. A Highly Efficient human pluripotent stem cell microglia model displays a neuronal-co-culture-specific expression profile and inflammatory response. Stem Cell Rep. 2017;8(6):1727\u201342. https:\/\/doi.org\/10.1016\/j.stemcr.2017.05.017.","journal-title":"Stem Cell Rep"},{"issue":"10","key":"4965_CR34","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, Vergallo A. The Amyloid-\u03b2 Pathway in Alzheimer\u2019s Disease. Mol Psychiatry. 2021;26(10):5481\u2013503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"4965_CR35","doi-asserted-by":"publisher","first-page":"611","DOI":"10.14336\/AD.2018.0707","volume":"10","author":"R Han","year":"2021","unstructured":"Han R, Liu Z, Sun N, Liu S, Li L, Shen Y, Xiu J, Xu Q. BDNF alleviates neuroinflammation in the hippocampus of type 1 diabetic mice via blocking the aberrant HMGB1\/RAGE\/NF-\u03baB Pathway. Aging Dis. 2021;10(3):611\u201325. https:\/\/doi.org\/10.14336\/AD.2018.0707.","journal-title":"Aging Dis"},{"key":"4965_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0297785","author":"WL He","year":"2024","unstructured":"He WL, Chang FX, Wang T, Sun BX, Chen RR, Zhao LP. Serum brain-derived neurotrophic factor levels in type 2 diabetes mellitus patients and its association with cognitive impairment: a meta-analysis. PLoS ONE. 2024. https:\/\/doi.org\/10.1371\/journal.pone.0297785.","journal-title":"PLoS ONE"},{"issue":"2","key":"4965_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/jnr.490260217","volume":"26","author":"R Hellweg","year":"1990","unstructured":"Hellweg R, Hartung H-D. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res. 1990;26(2):258\u201367. https:\/\/doi.org\/10.1002\/jnr.490260217.","journal-title":"J Neurosci Res"},{"issue":"7","key":"4965_CR38","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00125-007-0683-3","volume":"50","author":"PM Humpert","year":"2007","unstructured":"Humpert PM, Kopf S, Djuric Z, Laine K, Korosoglou G, Rudofsky G, Hamann A, Morcos M, Von Eynatten M, Nawroth PP, Bierhaus A. Levels of three distinct p75 neurotrophin receptor forms found in human plasma are altered in type 2 diabetic patients. Diabetologia. 2007;50(7):1517\u201322. https:\/\/doi.org\/10.1007\/s00125-007-0683-3.","journal-title":"Diabetologia"},{"issue":"9","key":"4965_CR39","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s00125-025-06491-7","volume":"68","author":"JJ Hwang","year":"2025","unstructured":"Hwang JJ, Bini J, Belfort-DeAguiar R. Measurement of brain glucose metabolism in obesity and diabetes. Diabetologia. 2025;68(9):1879\u201388. https:\/\/doi.org\/10.1007\/s00125-025-06491-7.","journal-title":"Diabetologia"},{"issue":"5","key":"4965_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5483\/BMBRep.2014.47.5.061","volume":"47","author":"SY Hyun","year":"2014","unstructured":"Hyun SY, Hwan HI, Jang YJ. Polo-like kinase-1 in DNA damage response. BMB Rep. 2014; 47(5): 249\u201355. https:\/\/doi.org\/10.5483\/BMBRep.2014.47.5.061","journal-title":"BMB Rep"},{"issue":"11","key":"4965_CR41","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1007\/s00417-019-04460-6","volume":"257","author":"R Ib\u00e1n-Arias","year":"2019","unstructured":"Ib\u00e1n-Arias R, Lisa S, Poulaki S, Mastrodimou N, Charalampopoulos I, Gravanis A, Thermos K. Effect of topical administration of the microneurotrophin BNN27 in the diabetic rat retina. Graefe\u2019s Arch Clin Exp Ophthalmol. 2019;257(11):2429\u201336. https:\/\/doi.org\/10.1007\/s00417-019-04460-6.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"4965_CR42","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.tiv.2019.06.019","volume":"60","author":"PA Iglesias Gonz\u00e1lez","year":"2019","unstructured":"Iglesias Gonz\u00e1lez PA, Conde MA, Gonz\u00e1lez-Pardo V, Uranga RM, Salvador GA. In vitro 6-hydroxydopamine-induced neurotoxicity: new insights on NF\u03baB modulation. Toxicol In Vitro. 2019;60:400\u201311. https:\/\/doi.org\/10.1016\/j.tiv.2019.06.019.","journal-title":"Toxicol In Vitro"},{"key":"4965_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020419","author":"M Kannavou","year":"2023","unstructured":"Kannavou M, Karali K, Katsila T, Siapi E, Marazioti A, Klepetsanis P, Calogeropoulou T, Charalampopoulos I, Antimisiaris SG. Development and comparative in vitro and in vivo study of BNN27 mucoadhesive liposomes and nanoemulsions for nose-to-brain delivery. Pharmaceutics. 2023;15(2). https:\/\/doi.org\/10.3390\/pharmaceutics15020419.","journal-title":"Pharmaceutics"},{"issue":"34","key":"4965_CR44","doi-asserted-by":"publisher","first-page":"10627","DOI":"10.1523\/JNEUROSCI.0620-09.2009","volume":"29","author":"JK Knowles","year":"2009","unstructured":"Knowles JK, Rajadas J, Nguyen TVV, Yang T, LeMieux MC, Griend V, Ishikawa L, Massa C, Wyss-Coray SM, T., Longo FM. The p75 neurotrophin receptor promotes amyloid-\u03b2(1\u201342)-induced neuritic dystrophy in vitro and in vivo. J Neurosci. 2009;29(34):10627\u201337. https:\/\/doi.org\/10.1523\/JNEUROSCI.0620-09.2009.","journal-title":"J Neurosci"},{"key":"4965_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02833-w","author":"M Kokkali","year":"2024","unstructured":"Kokkali M, Karali K, Thanou E, Papadopoulou MA, Zota I, Tsimpolis A, Efstathopoulos P, Calogeropoulou T, Li KW, Sidiropoulou K, Gravanis A, Charalampopoulos I. Multimodal beneficial effects of BNN27, a nerve growth factor synthetic mimetic, in the 5xFAD mouse model of Alzheimer\u2019s disease. Mol Psychiatry. 2024. https:\/\/doi.org\/10.1038\/s41380-024-02833-w.","journal-title":"Mol Psychiatry"},{"key":"4965_CR46","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3233\/JPD-212725","volume":"11","author":"K Komici","year":"2021","unstructured":"Komici K, Femminella GD, Bencivenga L, Rengo G, Pagano G. Diabetes mellitus and Parkinson\u2019s disease: a systematic review and meta-analyses. J Parkinson\u2019s Dis. 2021. 11:1585\u201396.","journal-title":"J Parkinson\u2019s Dis"},{"issue":"5","key":"4965_CR47","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.parkreldis.2013.01.016","volume":"19","author":"V Kotagal","year":"2013","unstructured":"Kotagal V, Albin RL, M\u00fcller MLTM, Koeppe RA, Frey KA, Bohnen NI. Diabetes is associated with postural instability and gait difficulty in Parkinson disease. Parkinsonism Relat Disorders. 2013;19(5):522\u20136. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.01.016.","journal-title":"Parkinsonism Relat Disord"},{"issue":"31","key":"4965_CR48","doi-asserted-by":"publisher","first-page":"21205","DOI":"10.1074\/jbc.M114.563403","volume":"289","author":"BR Kraemer","year":"2014","unstructured":"Kraemer BR, Snow JP, Vollbrecht P, Pathak A, Valentine WM, Deutch AY, Carter BD. A role for the p75 neurotrophin receptor in axonal degeneration and apoptosis induced by oxidative stress. J Biol Chem. 2014;289(31):21205\u201316. https:\/\/doi.org\/10.1074\/jbc.M114.563403.","journal-title":"J Biol Chem"},{"issue":"3","key":"4965_CR49","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.taap.2011.07.021","volume":"256","author":"C Latchoumycandane","year":"2011","unstructured":"Latchoumycandane C, Anantharam V, Jin H, Kanthasamy A, Kanthasamy A. Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKC\u03b4 in cell culture and animal models of Parkinson\u2019s disease. Toxicol Appl Pharmcol. 2011;256(3):314\u201323. https:\/\/doi.org\/10.1016\/j.taap.2011.07.021.","journal-title":"Toxicol Appl Pharmcol"},{"key":"4965_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03136-1","author":"KS Lee","year":"2024","unstructured":"Lee KS, Yoon SH, Hwang I, Ma JH, Yang E, Kim RH, Kim E, Yu JW. Hyperglycemia enhances brain susceptibility to lipopolysaccharide-induced neuroinflammation via astrocyte reprogramming. J Neuroinflamm. 2024. https:\/\/doi.org\/10.1186\/s12974-024-03136-1.","journal-title":"J Neuroinflamm"},{"key":"4965_CR51","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.brainres.2011.02.078","volume":"1387","author":"W Li","year":"2011","unstructured":"Li W, Poteet E, Xie L, Liu R, Wen Y, Yang SH. Regulation of matrix metalloproteinase 2 by oligomeric amyloid \u03b2 protein. Brain Res. 2011;1387:141\u20138. https:\/\/doi.org\/10.1016\/j.brainres.2011.02.078.","journal-title":"Brain Res"},{"issue":"7","key":"4965_CR52","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3390\/brainsci11070896","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y, Long W, Gao M, Jiao F, Chen Z, Liu M, Yu L. TREM2 regulates high glucose-induced microglial inflammation via the NLRP3 signaling pathway. Brain Sci. 2021;11(7):896. https:\/\/doi.org\/10.3390\/brainsci11070896.","journal-title":"Brain Sci"},{"issue":"6","key":"4965_CR53","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s10072-013-1605-4","volume":"35","author":"D Liu","year":"2014","unstructured":"Liu D, Zhang H, Gu W, Zhang M. Effects of exposure to high glucose on primary cultured hippocampal neurons: involvement of intracellular ROS accumulation. Neurol Sci. 2014;35(6):831\u20137. https:\/\/doi.org\/10.1007\/s10072-013-1605-4.","journal-title":"Neurol Sci"},{"key":"4965_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-05024-y","author":"M Llori\u00e1n-Salvador","year":"2024","unstructured":"Llori\u00e1n-Salvador M, Cabeza-Fern\u00e1ndez S, Gomez-Sanchez JA, de la Fuente AG. Glial cell alterations in diabetes-induced neurodegeneration. Cell Mol Life Sci. 2024. https:\/\/doi.org\/10.1007\/s00018-023-05024-y","journal-title":"Cell Mol Life Sci"},{"issue":"20","key":"4965_CR55","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1523\/JNEUROSCI.3547-05.2006","volume":"26","author":"SM Massa","year":"2006","unstructured":"Massa SM, Xie Y, Yang T, Harrington AW, Kim ML, Yoon SO, Kraemer R, Moore LA, Hempstead BL, Longo FM. Small, nonpeptide p75 NTR ligands induce survival signaling and inhibit proNGF-induced death. J Neurosci. 2006;26(20):5288\u2013300. https:\/\/doi.org\/10.1523\/JNEUROSCI.3547-05.2006.","journal-title":"J Neurosci"},{"issue":"5","key":"4965_CR56","doi-asserted-by":"publisher","first-page":"721","DOI":"10.4103\/1673-5374.156967","volume":"10","author":"RB Meeker","year":"2015","unstructured":"Meeker RB, Williams KS. The p75 neurotrophin receptor: at the crossroad of neural repair and death. Neural Regeneration Res. 2015;10(5):721\u20135. https:\/\/doi.org\/10.4103\/1673-5374.156967.","journal-title":"Neural Regeneration Res"},{"key":"4965_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00391","author":"TR Melzer","year":"2019","unstructured":"Melzer TR, Stark MR, Keenan RJ, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Grenfell S, Horne KL, Young BN, Pascoe MJ, Almuqbel MM, Wang J, Marsh SH, Miller DH, Dalrymple-Alford JC, Anderson TJ. Beta amyloid deposition is not associated with cognitive impairment in Parkinson\u2019s disease. Front Neurol. 2019. https:\/\/doi.org\/10.3389\/fneur.2019.00391.","journal-title":"Front Neurol"},{"issue":"5","key":"4965_CR58","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jcmm.12229","volume":"18","author":"X Meng","year":"2014","unstructured":"Meng X, Wang X, Tian X, Yang Z, Li M, Zhang C. Protection of neurons from high glucose-induced injury by deletion of MAD2B. J Cell Mol Med. 2014;18(5):844\u201351. https:\/\/doi.org\/10.1111\/jcmm.12229.","journal-title":"J Cell Mol Med"},{"key":"4965_CR59","doi-asserted-by":"crossref","unstructured":"Moran C, Beare R, Phan TG, Bruce DG, Callisaya ML, Srikanth V. Type 2 diabetes mellitus and biomarkers of neurodegeneration; 2015. https:\/\/ida.loni.usc.edu","DOI":"10.1212\/WNL.0000000000001982"},{"issue":"5","key":"4965_CR60","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s12015-015-9599-3","volume":"11","author":"M Morrison","year":"2015","unstructured":"Morrison M, Klein C, Clemann N, Collier DA, Hardy J, Heisserer B, Cader MZ, Graf M, Kaye J. StemBANCC: governing access to material and data in a large stem cell research consortium. Stem Cell Reviews Rep. 2015;11(5):681\u20137. https:\/\/doi.org\/10.1007\/s12015-015-9599-3.","journal-title":"Stem Cell Reviews Rep"},{"issue":"10","key":"4965_CR61","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1007\/s00125-013-2998-6","volume":"56","author":"BA Mysona","year":"2013","unstructured":"Mysona BA, Al-Gayyar MMH, Matragoon S, Abdelsaid MA, El-Azab MF, Saragovi HU, El-Remessy AB. Modulation of p75NTR prevents diabetes- and proNGF-induced retinal inflammation and blood-retina barrier breakdown in mice and rats. Diabetologia. 2013;56(10):2329\u201339. https:\/\/doi.org\/10.1007\/s00125-013-2998-6.","journal-title":"Diabetologia"},{"key":"4965_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14727","author":"A Nobili","year":"2017","unstructured":"Nobili A, Latagliata EC, Viscomi MT, Cavallucci V, Cutuli D, Giacovazzo G, Krashia P, Rizzo FR, Marino R, Federici M, De Bartolo P, Aversa D, Dell\u2019Acqua MC, Cordella A, Sancandi M, Keller F, Petrosini L, Puglisi-Allegra S, Mercuri NB, D\u2019Amelio M. Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease. Nat Commun. 2017. https:\/\/doi.org\/10.1038\/ncomms14727.","journal-title":"Nat Commun"},{"key":"4965_CR63","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neurobiolaging.2022.06.004","volume":"118","author":"C Palix","year":"2022","unstructured":"Palix C, Felisatti F, Gonneaud J, Kuhn E, M\u00e9zenge F, Landeau B, Chocat A, Quillard A, Egret S, Delarue M, Sayette VD, La, Vivien D, Ch\u00e9telat G, Poisnel G. Relationships between diabetes-related vascular risk factors and neurodegeneration biomarkers in healthy aging and Alzheimer\u2019s disease. Neurobiol Aging. 2022;118:25\u201333. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2022.06.004.","journal-title":"Neurobiol Aging"},{"key":"4965_CR64","doi-asserted-by":"publisher","DOI":"10.1093\/sexmed\/qfac009","author":"WD Pallas","year":"2023","unstructured":"Pallas WD, Pak ES, Hannan JL. In vitro high glucose increases apoptosis, decreases nerve outgrowth, and promotes survival of sympathetic pelvic neurons. Sex Med. 2023. https:\/\/doi.org\/10.1093\/sexmed\/qfac009.","journal-title":"Sex Med"},{"key":"4965_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411683","author":"MA Papadopoulou","year":"2023","unstructured":"Papadopoulou MA, Rogdakis T, Charou D, Peteinareli M, Ntarntani K, Gravanis A, Chanoumidou K, Charalampopoulos I. Neurotrophin analog ENT-A044 activates the p75 neurotrophin receptor, regulating neuronal survival in a cell context-dependent manner. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241411683.","journal-title":"Int J Mol Sci"},{"key":"4965_CR66","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.neuropharm.2016.09.007","volume":"111","author":"I Pediaditakis","year":"2016","unstructured":"Pediaditakis I, Efstathopoulos P, Prousis KC, Zervou M, Ar\u00e9valo JC, Alexaki VI, Nikoletopoulou V, Karagianni E, Potamitis C, Tavernarakis N, Chavakis T, Margioris AN, Venihaki M, Calogeropoulou T, Charalampopoulos I, Gravanis A. Selective and differential interactions of BNN27, a novel C17-spiroepoxy steroid derivative, with TrkA receptors, regulating neuronal survival and differentiation. Neuropharmacology. 2016;111:266\u201382. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.09.007.","journal-title":"Neuropharmacology"},{"key":"4965_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00512","author":"I Pediaditakis","year":"2016","unstructured":"Pediaditakis I, Kourgiantaki A, Prousis KC, Potamitis C, Xanthopoulos KP, Zervou M, Calogeropoulou T, Charalampopoulos I, Gravanis A. BNN27, a 17-spiroepoxy steroid derivative, interacts with and activates p75 neurotrophin receptor, rescuing cerebellar granule neurons from apoptosis. Front Pharmacol. 2016. https:\/\/doi.org\/10.3389\/fphar.2016.00512.","journal-title":"Front Pharmacol"},{"issue":"9","key":"4965_CR68","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/mds.28124","volume":"35","author":"I P\u00e9rez-Taboada","year":"2020","unstructured":"P\u00e9rez-Taboada I, Alberquilla S, Mart\u00edn ED, Anand R, Vietti-Michelina S, Tebeka NN, Cantley J, Cragg SJ, Moratalla R, Vallejo M. Diabetes causes dysfunctional dopamine neurotransmission favoring nigrostriatal degeneration in mice. Mov Disord. 2020;35(9):1636\u201348. https:\/\/doi.org\/10.1002\/mds.28124.","journal-title":"Mov Disord"},{"key":"4965_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100902","author":"S Perriot","year":"2021","unstructured":"Perriot S, Canales M, Mathias A, Du Pasquier R. Differentiation of functional astrocytes from human-induced pluripotent stem cells in chemically defined media. STAR Protocols. 2021. https:\/\/doi.org\/10.1016\/j.xpro.2021.100902.","journal-title":"STAR Protocols"},{"issue":"1","key":"4965_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbadis.2016.09.013","volume":"1863","author":"A Quincozes-Santos","year":"2017","unstructured":"Quincozes-Santos A, Bobermin LD, de Assis AM, Gon\u00e7alves CA, Souza DO. Fluctuations in glucose levels induce glial toxicity with glutamatergic, oxidative and inflammatory implications. Biochim et Biophys Acta Mol Basis Dis. 2017;1863(1):1\u201314. https:\/\/doi.org\/10.1016\/j.bbadis.2016.09.013.","journal-title":"Biochim et Biophys Acta Mol Basis Dis"},{"key":"4965_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s41984-023-00255-4","author":"L Quintana-Pajaro","year":"2023","unstructured":"Quintana-Pajaro L, Padilla-Zambrano HS, Ramos-Villegas Y, Lopez-Cepeda D, Andrade-Lopez A, Hoz S, Moscote-Salazar LR, Joaquim AF, Perdomo F, W. A., Janjua T. Cerebral traumatic injury and glucose metabolism: a scoping review. Egypt J Neurosurg. 2023. https:\/\/doi.org\/10.1186\/s41984-023-00255-4.","journal-title":"Egypt J Neurosurg"},{"key":"4965_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/genes14010144","author":"MA Rahmoon","year":"2023","unstructured":"Rahmoon MA, Elghaish RA, Ibrahim AA, Alaswad Z, Gad MZ, El-Khamisy SF, Elserafy M. High glucose increases DNA damage and elevates the expression of multiple DDR genes. Genes. 2023. https:\/\/doi.org\/10.3390\/genes14010144.","journal-title":"Genes"},{"key":"4965_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059252","author":"P Reinhardt","year":"2013","unstructured":"Reinhardt P, Glatza M, Hemmer K, Tsytsyura Y, Thiel CS, H\u00f6ing S, Moritz S, Parga JA, Wagner L, Bruder JM, Wu G, Schmid B, R\u00f6pke A, Klingauf J, Schwamborn JC, Gasser T, Sch\u00f6ler HR, Sterneckert J. Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PLoS ONE. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0059252.","journal-title":"PLoS ONE"},{"key":"4965_CR74","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neurobiolaging.2018.05.010","volume":"69","author":"J Renaud","year":"2018","unstructured":"Renaud J, Bassareo V, Beaulieu J, Pinna A, Schlich M, Lavoie C, Murtas D, Simola N, Martinoli MG. Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway. Neurobiol Aging. 2018;69:117\u201328. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.05.010.","journal-title":"Neurobiol Aging"},{"key":"4965_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00810","author":"C Ripoli","year":"2020","unstructured":"Ripoli C, Spinelli M, Natale F, Fusco S, Grassi C. Glucose overload inhibits glutamatergic synaptic transmission: a novel role for CREB-mediated regulation of synaptotagmins 2 and 4. Front Cell Dev Biol. 2020. https:\/\/doi.org\/10.3389\/fcell.2020.00810.","journal-title":"Front Cell Dev Biol"},{"key":"4965_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1125628","author":"K Rodolaki","year":"2023","unstructured":"Rodolaki K, Pergialiotis V, Iakovidou N, Boutsikou T, Iliodromiti Z, Kanaka-Gantenbein C. The impact of maternal diabetes on the future health and neurodevelopment of the offspring: a review of the evidence. Front Endocrinol. 2023. https:\/\/doi.org\/10.3389\/fendo.2023.1125628.","journal-title":"Front Endocrinol"},{"key":"4965_CR77","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbrc.2021.11.108","volume":"589","author":"S Sasaki-Hamada","year":"2022","unstructured":"Sasaki-Hamada S, Sanai E, Kanemaru M, Kamanaka G, Oka JI. Long-term exposure to high glucose induces changes in the expression of AMPA receptor subunits and glutamate transmission in primary cultured cortical neurons. Biochem Biophys Res Commun. 2022;589:48\u201354. https:\/\/doi.org\/10.1016\/j.bbrc.2021.11.108.","journal-title":"Biochem Biophys Res Commun"},{"key":"4965_CR78","doi-asserted-by":"crossref","unstructured":"Scarpini E, Conti G, Chianese L, Baron P, Pizzul S, Basellini A, Livraghi S, Scarlato G. Induction of ~\u200975 NGFR in human diabetic neuropathy. J Neurological Sci. 1996;135.","DOI":"10.1016\/0022-510X(95)00260-9"},{"issue":"52","key":"4965_CR79","doi-asserted-by":"publisher","first-page":"43798","DOI":"10.1074\/jbc.M112.374710","volume":"287","author":"S Skeldal","year":"2012","unstructured":"Skeldal S, Sykes AM, Glerup S, Matusica D, Palstra N, Autio H, Boskovic Z, Madsen P, Castr\u00e9n E, Nykjaer A, Coulson EJ. Mapping of the interaction site between sortilin and the p75 neurotrophin receptor reveals a regulatory role for the sortilin intracellular domain in p75 neurotrophin receptor shedding and apoptosis. J Biol Chem. 2012;287(52):43798\u2013809. https:\/\/doi.org\/10.1074\/jbc.M112.374710.","journal-title":"J Biol Chem"},{"key":"4965_CR80","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bbi.2020.07.023","volume":"89","author":"A Speidell","year":"2020","unstructured":"Speidell A, Asuni GP, Wakulski R, Mocchetti I. Up-regulation of the p75 neurotrophin receptor is an essential mechanism for HIV-gp120 mediated synaptic loss in the striatum. Brain Behav Immun. 2020;89:371\u20139. https:\/\/doi.org\/10.1016\/j.bbi.2020.07.023.","journal-title":"Brain Behav Immun"},{"key":"4965_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2020.146702","author":"K Staricha","year":"2020","unstructured":"Staricha K, Meyers N, Garvin J, Liu Q, Rarick K, Harder D, Cohen S. Effect of high glucose condition on glucose metabolism in primary astrocytes. Brain Res. 2020. https:\/\/doi.org\/10.1016\/j.brainres.2020.146702.","journal-title":"Brain Res"},{"issue":"3","key":"4965_CR82","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3892\/etm.2014.1812","volume":"8","author":"Y Sun","year":"2014","unstructured":"Sun Y, Zhang Y, Li N, Zhang H, Zhou L, Shao L. Exposure to high levels of glucose increases the expression levels of genes involved in cholesterol biosynthesis in rat islets. Experimental Therapeutic Med. 2014;8(3):991\u20137. https:\/\/doi.org\/10.3892\/etm.2014.1812.","journal-title":"Experimental Therapeutic Med"},{"issue":"2","key":"4965_CR83","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1523\/JNEUROSCI.0399-12.2013","volume":"33","author":"C Tep","year":"2013","unstructured":"Tep C, Lim TH, Ko PO, Getahun S, Ryu JC, Goettl VM, Massa SM, Basso M, Longo FM, Yoon SO. Oral administration of a small molecule targeted to block proNGF binding to p75 promotes myelin sparing and functional recovery after spinal cord injury. J Neurosci. 2013;33(2):397\u2013410. https:\/\/doi.org\/10.1523\/JNEUROSCI.0399-12.2013.","journal-title":"J Neurosci"},{"issue":"1","key":"4965_CR84","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrn2294","volume":"9","author":"DR Tomlinson","year":"2008","unstructured":"Tomlinson DR, Gardiner NJ. Glucose neurotoxicity. Nat Rev Neurosci. 2008;9(1):36\u201345. https:\/\/doi.org\/10.1038\/nrn2294.","journal-title":"Nat Rev Neurosci"},{"key":"4965_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.724","author":"C Tsika","year":"2021","unstructured":"Tsika C, Tzatzarakis MN, Antimisiaris SG, Tsoka P, Efstathopoulos P, Charalampopoulos I, Gravanis A, Tsilimbaris MK. Quantification of BNN27, a novel neuroprotective 17-spiroepoxy dehydroepiandrosterone derivative in the blood and retina of rodents, after single intraperitoneal administration. Pharmacol Res Perspect. 2021. https:\/\/doi.org\/10.1002\/prp2.724.","journal-title":"Pharmacol Res Perspect"},{"key":"4965_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071098","author":"B van Wilgenburg","year":"2013","unstructured":"van Wilgenburg B, Browne C, Vowles J, Cowley SA. Efficient, long term production of monocyte-derived macrophages from human pluripotent stem cells under partly-defined and fully-defined conditions. PLoS ONE. 2013. https:\/\/doi.org\/10.1371\/journal.pone.0071098.","journal-title":"PLoS ONE"},{"issue":"4","key":"4965_CR87","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.stemcr.2018.08.013","volume":"11","author":"V Volpato","year":"2018","unstructured":"Volpato V, Smith J, Sandor C, Ried JS, Baud A, Handel A, Newey SE, Wessely F, Attar M, Whiteley E, Chintawar S, Verheyen A, Barta T, Lako M, Armstrong L, Muschet C, Artati A, Cusulin C, Christensen K, Lakics V. Reproducibility of molecular phenotypes after long-term differentiation to human iPSC-derived neurons: a multi-site omics study. Stem Cell Rep. 2018;11(4):897\u2013911. https:\/\/doi.org\/10.1016\/j.stemcr.2018.08.013.","journal-title":"Stem Cell Rep"},{"issue":"16","key":"4965_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph17134805","volume":"17","author":"SY Wang","year":"2020","unstructured":"Wang SY, Wu SL, Chen TC, Chuang CS. Antidiabetic agents for treatment of Parkinson\u2019s disease: a meta-analysis. Int J Environ Res Public Health. 2020; 17(13): 1\u201311. https:\/\/doi.org\/10.3390\/ijerph17134805","journal-title":"Int J Environ Res Public Health"},{"key":"4965_CR89","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005921","author":"YW Yang","year":"2017","unstructured":"Yang YW, Hsieh TF, Li CI, Liu CS, Lin WY, Chiang JH, Li TC, Lin CC. Increased risk of Parkinson disease with diabetes mellitus in a population-based study. Medicine (United States). 2017. https:\/\/doi.org\/10.1097\/MD.0000000000005921.","journal-title":"Medicine (United States)"},{"key":"4965_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1422746","author":"B Zhang","year":"2024","unstructured":"Zhang B, Song C, Tang X, Tian M, Liu Y, Yan Z, Duan R, Liu Y. Type 2 diabetes microenvironment promotes the development of Parkinson\u2019s disease by activating microglial cell inflammation. Front Cell Dev Biol. 2024. https:\/\/doi.org\/10.3389\/fcell.2024.1422746","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"4965_CR91","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3892\/ijmm.2018.3933","volume":"43","author":"Y Zhong","year":"2019","unstructured":"Zhong Y, Zhu Y, He T, Li W, Li Q, Miao Y. Brain-derived neurotrophic factor inhibits hyperglycemia-induced apoptosis and downregulation of synaptic plasticity-related proteins in hippocampal neurons via the PI3K\/Akt pathway. Int J Mol Med. 2019;43(1):294\u2013304. https:\/\/doi.org\/10.3892\/ijmm.2018.3933.","journal-title":"Int J Mol Med"},{"key":"4965_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00193","author":"W Zhou","year":"2019","unstructured":"Zhou W, Yao Y, Li J, Wu D, Zhao M, Yan Z, Pang A, Kong L. TIGAR attenuates high glucose-induced neuronal apoptosis via an autophagy pathway. Front Mol Neurosci. 2019. https:\/\/doi.org\/10.3389\/fnmol.2019.00193.","journal-title":"Front Mol Neurosci"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-04965-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04965-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04965-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:45:50Z","timestamp":1777430750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-04965-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4965"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-04965-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7184834\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The human iPSC lines provided by Dr \u039c. Z. Cader were derived from human skin biopsy fibroblasts, following signed informed consent, with approval from the UK NHS Research Ethics Committee (REC: 13\/SC\/0179 and 10\/H0505\/71, Study Title: Stem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC), Date 09\/05\/2013) and were derived as part of the IMI-EU sponsored StemBANCC consortium. The human iPSC line provided by Prof. Gr\u00fcnewald was derived from female donor fibroblasts, following research consent from the patient and \u201cCNER\u201d stands for Comit\u00e9 National d\u2019Ethique de Recherche (CNER N\u00b0 201411, Study Title: Disease modelling of Parkinson\u2019s disease using patient-derived fibroblasts and induced pluripotent stem cells (DiMo-PD), Date 04\/10\/2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have not use AI-generated work in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of Artificial Intelligence"}},{"value":"All authors, except Achille Gravanis, declare that they have not any competing financial interests in relation to the work described. Dr Achille Gravanis is the co-founder of spin-off Bionature EA LTD, proprietary of compound BNN27 (patented with the WO 2008\/ 1555 34 A2 number at the World Intellectual Property Organization). Gravanis A is co-founder of Bionature E.A. Ltd. The BNN compounds are proprietary and patented by the Bionature E.A. Ltd (http:\/\/www.bionature.net) (Patent Number: WO2008\/155534 A2).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}